AGILE THERAPEUTICS INC financial data

Location
Princeton, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 12 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 54% % -36%
Quick Ratio 17% % 28%
Debt-to-equity -180% % 39%
Return On Equity 104% % -59%
Return On Assets -130% % -0.71%
Operating Margin -63% % 73%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,904,498 shares 258%
Common Stock, Shares, Outstanding 6,904,498 shares 321%
Common Stock, Value, Issued $5,000 USD
Weighted Average Number of Shares Outstanding, Basic 6,856,229 shares 287%
Weighted Average Number of Shares Outstanding, Diluted 6,856,229 shares 287%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $21,569,000 USD 32%
Cost of Revenue $7,844,000 USD 6.2%
Research and Development Expense $1,792,000 USD -31%
Selling and Marketing Expense $15,987,000 USD -26%
General and Administrative Expense $9,499,000 USD -13%
Operating Income (Loss) $13,553,000 USD 64%
Nonoperating Income (Expense) $2,301,000 USD -113%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $15,854,000 USD 17%
Net Income (Loss) Attributable to Parent $15,855,000 USD 17%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,848,000 USD 2.3%
Accounts Receivable, after Allowance for Credit Loss, Current $4,550,000 USD 2%
Inventory, Net $5,793,000 USD 128%
Assets, Current $14,443,000 USD 24%
Property, Plant and Equipment, Net $27,000 USD -79%
Operating Lease, Right-of-Use Asset $255,000 USD -54%
Other Assets, Noncurrent $238,000 USD 0%
Assets $14,963,000 USD 19%
Accounts Payable, Current $16,543,000 USD 169%
Employee-related Liabilities, Current $954,000 USD -57%
Accrued Liabilities, Current $9,396,000 USD 39%
Liabilities, Current $26,228,000 USD 71%
Liabilities $36,875,000 USD 49%
Retained Earnings (Accumulated Deficit) $433,756,000 USD -3.8%
Stockholders' Equity Attributable to Parent $21,912,000 USD -81%
Liabilities and Equity $14,963,000 USD 19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,476,000 USD -55%
Net Cash Provided by (Used in) Financing Activities $2,535,000 USD 226%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 6,904,498 shares 321%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $59,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,848,000 USD 2.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities $50,000 USD -47%
Operating Lease, Liability $289,000 USD -54%
Depreciation $26,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid $300,000 USD -57%
Operating Lease, Liability, Current $289,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $101,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $199,000 USD -50%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,000 USD -83%
Preferred Stock, Shares Issued 4,850 shares 0%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $87,000 USD 13%
Additional Paid in Capital $411,839,000 USD 1.5%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $284,000 USD -41%
Interest Expense $1,202,000 USD -55%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%